INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2014

Genistein targets pathways of prostate cancer detachment, invasion, and metastasis at concentrations attainable via diet.

This review examines preclinical and clinical evidence on genistein, a compound found in high amounts in soy, in preventing prostate cancer metastasis. In vitro, rodent models, and prospective human clinical trials support genistein as an antimetastatic agent that inhibits cell detachment, protease production, and invasion at dietary concentrations. Phase I and phase II trials showed that concentrations associated with antimetastatic efficacy in models are achievable in humans and that genistein inhibits pathways regulating metastatic transformation in human prostate tissue.

Study type
Narrative review
Who was studied
Men with or at risk for prostate cancer, along with preclinical models
What was measured
Prostate cancer metastasis, cell detachment, invasion, and metastatic pathway regulation

THE PAPER

Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis.

Pavese JM, Krishna SN, Bergan RC. Am J Clin Nutr, 2014.

PubMed 24871471 ↗DOI 10.3945/ajcn.113.071290 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.